Tagged Articles

Lunesta 5 articles

New sleeping pill gets FDA approval, awaits DEA clearance

A new type of prescription sleep aid has won approval from the Food and Drug Administration (FDA) and if given clearance from the Drug Enforcement Administration (DEA) should be commercially available later this year. Belsomra, made by Merck & Co., works by temporarily blocking chemicals in the brain that control sleep cycle and keep people awake at night. The sleeping pill is designed to help people with insomnia to sleep through the night. Belsomra was approved based on trials that pitted the medication against a placebo. It was not tested against other sleep aids, however, so it is not known ... Read More

Sleeping pills, anti-anxiety drugs send more people to the ER

Bad reactions to anti-anxiety medications and sedatives send more people to the emergency room than any other drugs, according to a new study published in JAMA Psychiatry. The findings come from an analysis of medical records from 63 hospitals from 2009 to 2011. Researchers noted that most of the ER visits involved adverse side effects or overdoses, and nearly 20 percent of those resulted in hospitalizations. The biggest problem-maker was the sedative zolpidem tartrate, the active ingredient in the brand-name sleep aid Ambien. The drug is available in other brands as well as in generic. The drug accounted for nearly ... Read More

FDA warns of next-day impairment with sleep aid Lunesta

The insomnia drug Lunesta (eszopiclone) can linger in users’ bloodstreams hours longer than intended, causing impairment of driving and other activities that require alertness, the Food and Drug Administration warned. The agency is recommending that starting doses be lowered to 1 mg at bedtime for both men and women. The drug labels for Lunesta and its generic counterparts will be updated to reflect the new warnings and recommended dosing. The new dosing is based on a study that found that the previously recommended dose of 3 mg can cause impairment of driving skills, memory and coordination that can last more ... Read More

North Carolina woman says prescription drug-induced psychosis led husband to kill daughters

The moment Kim Crespi of Charlotte, N.C., heard that her husband David had stabbed their 5-year-old twin daughters to death, she knew that the real culprit behind the horrific act wasn’t her spouse but a cocktail of prescription drugs, including Selective Serotonin Reuptake Inhibitors, or SSRIs – a form of antidepressants. According to Charlotte’s WBTV, David Crespi, a Charlotte-area banker, called 911 on the morning of Jan. 20, 2006 to report that he had just killed his own daughters. Mr. Crespi was arrested and ultimately took a plea bargain to avoid the death penalty. He is now serving two life ... Read More

Sleep aid may increase risk of hip fracture in nursing home patients

Sleep aids are commonly given to nursing home patients to help them rest, but a new study shows that a popular type prescription sleeping pill might put patients at increased risk for hip fractures. Researchers at Harvard Medical School in Boston reviewed data from more than 15,500 nursing home residents who experienced a hip fracture between July 2007 and December 2008. About 1,700 of them were given a nonbenzodiazepine hypnotic sleep aid before their hip fracture. These drugs include the brand names Lunesta, Sonata, Ambien and Intermezzo. Researchers determined that patients who took these drugs were two-thirds more likely to experience a ... Read More